Developing psychiatric pharmacy practice
A request from the medical director to review the prescribing of psychotropic drugs in a small hospital serving the Navajo population stimulated a career interest in psychiatric disease… read more.
A request from the medical director to review the prescribing of psychotropic drugs in a small hospital serving the Navajo population stimulated a career interest in psychiatric disease… read more.
Obese mice that were fed a high-fat diet and that received prednisone one time per week had improved exercise endurance, got stronger, increased their lean body mass and… read more.
Early in his career Professor Lynn Crismon worked in the US Public Health Service on the Navajo reservation where he learned much about communicable diseases, including bubonic plague…. read more.
Professor M Lynn Crismon received the 2021 American Society of Health System Pharmacists award for excellence in pharmacy practice leadership. IMI spoke to him to find out more… read more.
Pharmacogenomic testing for safety and efficacy of common medicines should be offered via the NHS, according to a report from the Royal College of Physicians and the British… read more.
Pfizer and OPKO Health announced that the European Commission has granted marketing authorization for the next-generation long-acting recombinant human growth hormone Ngenla (somatrogon), a once-weekly injection to treat… read more.
An analysis of the records more than 41,000 patients who had covid-19 and were treated with either ivermectin or remdesivir showed that ivermectin was associated with significantly lower… read more.
Antibiotics are a double-edged sword: on the one hand, antibiotics are essential to curing bacterial infections. On the other, their use promotes the appearance and proliferation of antibiotic-resistant… read more.
NICE (UK): Keytruda (pembrolizumab), from Merck Inc. with carboplatin and paclitaxel is recommended as an option for untreated metastatic squamous non-small-cell lung cancer (NSCLC) in adults, only if… read more.
Sandoz has announced the launch of generic oncology medicine lenalidomide, indicated for several haemato-oncology conditions as recommended by the latest European Society for Medical Oncology (ESMO) guidelines. The… read more.
Results from an international, randomized, double-blind, placebo-controlled, phase 3 clinical trial indicate that adding the androgen-receptor inhibitor darolutamide to androgen-deprivation therapy and chemotherapy prolongs the survival of men… read more.
Will artificial intelligence (AI) change the traditional trial–and–error drug development process and become a revolutionary force in the pharmaceutical sector? Active learning and interpretable AI are the two… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.